Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
The Oncologists Consultants will do the prescribing. They will decide/dictate which chemo drug to use on the patient. Doxorubicin is very well known to them. It has been around for 20+ years. It is very toxic and the Oncologists have been restricted to using this drug for only young and fit healthy people .. albeit with cancer. Now the Oncologists will be able to use it on older patients, safety, no bald heads, etc; i.e. Chemo with no side effects ... They can increase the dosage levels to just the targeted cancer cells to levels never achieved before without harming the healthy cells..
Read that bit again CHEMO WITH NO SIDE EFFECTS
This is the Oncologist HOLY GRAIL
The PreCision technology is new, but the drug only becomes toxic once it is inside the cancer cell... I call it the Trojan Horse. This technology will BLOW THE F**KING DOORS OFF (where is Michael Caine?). Once the oncologists see the full potential, all the big Pharma players in the Chemo Industry will be fighting to get a slice .. Watch the share price rocket and rocket as the pipeline is looking good.
I would call it a shop window .. rather than a lab in London. It would be quite easy/convenient for the directors of international pharma companies to pop in.. Heathrow Airport is on the doorstep. You have a one-stop-shop where you can have legal representatives, international banks and money markets all based in one city to secure/broker deals. It makes perfect sense to have a representation based in London.
I am not London centric, but to have a London office/base makes perfect sense. And to be adjacent (in bed so to speak!) with your partners is great for communication/collaboration. It is all good.
My hearing is getting bad ..
did you say kill that rumour??
I meant stating
I meant stating
I guess it depends on how it is marketed..
If it has TESCO finest, British made, proven to detect Oricron variants.. people will happily pay the extra..
I can't see many other LFT starng they can detect Ormicron...
For the above characteristics, I believe people would pay more..
I am confused
We are in 2022??
Maybe the Price Monitoring Extensions are FOC to the company and are provided to service/explain to the market if there is a shortage of shares (temporary illiquidity? is there such a word?).
I am assuming that to be the reason.
I am new to AIM and shares .. and the whole thing is a new language.
I have learnt very quickly to recognise a troll and ignore the baskets (or possibly do the exact opposite of what they promoting).
GOOD LUCK EVERYBODY
If ýou can't buy .. then I guess it will be tricky to move shares from your trading account into your ISA account. This concerns me.
Look at the 7.55% spread !!!
I was thinking about this same thing the other day. If your broker and/or ISA managers sell and then buys your shares back, as the spread between the sell and buy can be as much as 5%.. you could lose out. How would you feel if news about the new drug was released just after you sell, but before the broker buysback the shares within the ISA wrapper. This could be catastrophic.. I am concerned about it. I will be moving 2 x £20K (my own and my wife's) shares.. and I really don't know the best way to do it. I was thinking of doing it in 4 x £5k tranches.. over 2 to 3 weeks.
But I would be interested what/how other people do it. I am with Intereactive Investor.. ii.com
WOW
I don't think they would present any data to a candidate, potential non-executive other than verbal. It is too sensitive. Also, from previous employments, she knows some of the other researchers. I am sure they discuss data with colleagues, but I don't think anything formal (written down/graphs/charts) would have been sent. It is just too sensitive.
But I am even more excited that she is joining up with Avacta than before. The future is looking very exciting.
I think this is the lady
https://www.linkedin.com/in/christina-coughlin-809abb13
More goodies to the picnic... I wish her well
https://avacta.com/about/people/
Christina Coughlin was appointed because she was the best candidate for the job. Being, a woman (black/white/yellow) makes no difference whatsoever. I am a bloke and I am offended that my daughter/wife have to endure idiots like Roundhowe. Dr Christina Coughlin's resume says it all. Good Luck Christina in your new role. I hope you smash it.
Non Executive Director
Christina Coughlin, MD, PhD is the Chief Executive Officer of CytoImmune Therapeutics. Dr. Coughlin joined CytoImmune from Rubius Therapeutics, Inc. where she served as the Chief Medical Officer and led the clinical development, translational medicine and regulatory efforts in the allogeneic red cell therapy platform. Prior to Rubius, Dr. Coughlin was with Tmunity Therapeutics, Inc., where she served as Chief Medical Officer and was responsible for the development of autologous CAR-T and TCR-T cellular therapies. Dr. Coughlin served as the Chief Medical Officer for Immunocore, Ltd where she led the development of KimmtrakTM, recently approved for the treatment of metastatic uveal melanoma. Dr. Coughlin has held other leadership roles in the pharmaceutical and biotechnology fields in her career including Oncology Asset Team Leader at Pfizer and Clinical Program Team Lead at Novartis. Dr. Coughlin is an oncologist and immunologist, having received her M.D. and Ph.D. from the University of Pennsylvania and completed fellowships in Hematology and Oncology at the Children’s Hospital of Philadelphia and in the Translational Research Group under the direction of Carl June, M.D. at the University of Pennsylvania !
Sisu,
Are you Australian??
Drinking from a shoe has historically been performed as both a bringer of good fortune, a hazing punishment, or a party piece. Drinking champagne from a lady's slipper became a symbol of decadence in the early 20th century. The practice remains particularly popular in Australia, where it is called (doing) a shoey...
I have never heard of the expression.. but then, I have led a sheltered life.
Situation,
Are you Australian??
Drinking from a shoe has historically been performed as both a bringer of good fortune, a hazing punishment, or a party piece. Drinking champagne from a lady's slipper became a symbol of decadence in the early 20th century. The practice remains particularly popular in Australia, where it is called (doing) a shoey...
I have never heard of the expression.. but then, I have led a sheltered life.
Why is it so quiet today??
% short Date changed
Jupiter Investment Management Limited 0.58% 3 Mar 2022
Jupiter Investment Management Limited 0.68% 1 Mar 2022
Jupiter Investment Management Limited 0.88% 22 Feb 2022
Jupiter Investment Management Limited 1.03% 3 Feb 2022
Bronte Capital Management Pty Ltd 0.50% 21 Jan 2022
I thought they were closing their books on this .. apparently not. But this data it is only up to 3rd March which is nearly two weeks ago.
Me too ..
I hope with whatever crap that you are going through, you will find strength knowing that people genuinely care for you. You are def. one of the good eggs on here. We look forward to having you back soon.